Not one, not two, but three brain disease treatments

US biotech NeuroPhage Pharmaceuticals has raised finance to develop brain disease treatment products based on the discovery of Tel Aviv University professor Beka Solomon. Prof Solomon’s discovery is already being used by Elan Corporation (USA) and Israel’s NasVax to develop treatments for neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.